JP5982009B2 - Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン - Google Patents

Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン Download PDF

Info

Publication number
JP5982009B2
JP5982009B2 JP2014549442A JP2014549442A JP5982009B2 JP 5982009 B2 JP5982009 B2 JP 5982009B2 JP 2014549442 A JP2014549442 A JP 2014549442A JP 2014549442 A JP2014549442 A JP 2014549442A JP 5982009 B2 JP5982009 B2 JP 5982009B2
Authority
JP
Japan
Prior art keywords
bac
khv
recombinant
koi herpesvirus
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014549442A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015503914A (ja
Inventor
バンデルプラシエン，アラン，フランシス，クロード
Original Assignee
ゲスバル・ソシエテ・アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ゲスバル・ソシエテ・アノニム filed Critical ゲスバル・ソシエテ・アノニム
Publication of JP2015503914A publication Critical patent/JP2015503914A/ja
Application granted granted Critical
Publication of JP5982009B2 publication Critical patent/JP5982009B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16061—Methods of inactivation or attenuation
    • C12N2710/16062—Methods of inactivation or attenuation by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Farming Of Fish And Shellfish (AREA)
JP2014549442A 2011-12-30 2012-12-20 Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン Active JP5982009B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11196171 2011-12-30
EP11196171.0 2011-12-30
PCT/EP2012/076496 WO2013098214A1 (en) 2011-12-30 2012-12-20 A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016081363A Division JP2016195593A (ja) 2011-12-30 2016-04-14 Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン

Publications (2)

Publication Number Publication Date
JP2015503914A JP2015503914A (ja) 2015-02-05
JP5982009B2 true JP5982009B2 (ja) 2016-08-31

Family

ID=47429841

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014549442A Active JP5982009B2 (ja) 2011-12-30 2012-12-20 Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン
JP2016081363A Pending JP2016195593A (ja) 2011-12-30 2016-04-14 Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン
JP2018002936A Withdrawn JP2018078903A (ja) 2011-12-30 2018-01-11 Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016081363A Pending JP2016195593A (ja) 2011-12-30 2016-04-14 Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン
JP2018002936A Withdrawn JP2018078903A (ja) 2011-12-30 2018-01-11 Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン

Country Status (18)

Country Link
US (2) US20140348875A1 (enExample)
EP (1) EP2797627B1 (enExample)
JP (3) JP5982009B2 (enExample)
CN (1) CN104159609B (enExample)
BR (1) BR112014016117A2 (enExample)
HU (1) HUE053075T2 (enExample)
IL (1) IL232902A0 (enExample)
IN (1) IN2014CN04655A (enExample)
MD (1) MD4481C1 (enExample)
MX (1) MX361408B (enExample)
PH (1) PH12014501388A1 (enExample)
PL (1) PL2797627T3 (enExample)
RS (1) RS61261B1 (enExample)
RU (1) RU2662768C2 (enExample)
SG (1) SG11201403066TA (enExample)
TW (1) TWI484034B (enExample)
UA (2) UA119786C2 (enExample)
WO (1) WO2013098214A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018078903A (ja) * 2011-12-30 2018-05-24 ゲスバル・ソシエテ・アノニム Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017177071A1 (en) * 2016-04-08 2017-10-12 William Marsh Rice University Improved galactose utilization
CN112279898B (zh) * 2018-11-05 2022-06-21 共鳞实业(深圳)有限公司 预防或治疗鱼类感染CyHV-2的试剂及其应用
EP3662929A1 (en) * 2018-12-07 2020-06-10 IDT Biologika GmbH A recombinant koi herpesvirus (khv) and a diva vaccine for preventing and/or treating a disease caused by khv
CN110101854B (zh) * 2019-05-14 2022-08-02 四川农业大学 一种鲤疱疹病毒ⅲ型疫苗及其制备方法
CN110452926B (zh) * 2019-08-07 2022-06-17 西北农林科技大学 一种展示CyHV-2膜蛋白的重组杆状病毒及其制备方法和应用
CN110468111B (zh) * 2019-08-07 2022-06-17 西北农林科技大学 一种展示CyHV-2膜蛋白的重组杆状病毒及其制备方法和应用
CN113679832A (zh) * 2021-05-24 2021-11-23 苏州大学 一种利用冷冻干燥制备杆状病毒载鲤疱疹病毒ii型dna疫苗的方法
CN115960903B (zh) * 2022-12-23 2023-09-08 中国水产科学研究院淡水渔业研究中心 一种抑制CyHV-2病毒增殖的反义RNA组、重组载体和纳米粒递送系统及应用
CN120775802B (zh) * 2025-06-13 2026-04-21 中国水产科学研究院珠江水产研究所 一种鲤疱疹病毒3型orf136基因失活株及其制备方法和应用
CN120775801B (zh) * 2025-06-13 2026-07-31 中国水产科学研究院珠江水产研究所 一种鲤疱疹病毒3型orf138基因失活株及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115862T1 (de) 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
DE19733364A1 (de) 1997-08-01 1999-02-04 Koszinowski Ulrich H Prof Verfahren zur Klonierung eines großen Virusgenoms
IL153775A0 (en) 2003-01-01 2003-07-31 Yissum Res Dev Co Immunizing fish against viral infection
JP2007223913A (ja) * 2006-02-21 2007-09-06 Kyoritsu Seiyaku Kk コイヘルペスウイルス病ワクチン
EP2011876B1 (en) * 2006-04-13 2014-11-12 National University Corporation Tokyo University of Marine Science and Technology Dna vaccine for koi herpes virus (khv) disease
RU2010111725A (ru) * 2007-08-28 2011-10-10 Юниверсите Де Льеж (Be) Рекомбинантный герпесвирус кои (khv) или герпесвирус 3 семейства карповых (cyhv-3) и вакцина для профилактики заболевания, вызванного khv/cyhv-3 у cyprinus carpio или cyprinus carpio koi
DE102007041332A1 (de) * 2007-08-31 2009-03-05 Siemens Ag Transferchuck zur Übertragung, insbesondere von Wafern
IN2014CN04655A (enExample) * 2011-12-30 2015-09-18 Université de Liège

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018078903A (ja) * 2011-12-30 2018-05-24 ゲスバル・ソシエテ・アノニム Ｋｈｖにより引き起こされる疾患の防止のための組換えコイヘルペスウイルス（ｋｈｖ）およびワクチン

Also Published As

Publication number Publication date
SG11201403066TA (en) 2014-10-30
BR112014016117A2 (pt) 2018-09-25
EP2797627B1 (en) 2020-10-07
CN104159609B (zh) 2018-05-22
EP2797627A1 (en) 2014-11-05
HUE053075T2 (hu) 2021-06-28
US9931396B2 (en) 2018-04-03
CN104159609A (zh) 2014-11-19
WO2013098214A1 (en) 2013-07-04
MD4481B1 (ro) 2017-05-31
MD20120127A2 (en) 2013-07-31
JP2018078903A (ja) 2018-05-24
TWI484034B (zh) 2015-05-11
MX2014008045A (es) 2014-10-24
MX361408B (es) 2018-12-04
IN2014CN04655A (enExample) 2015-09-18
TW201333201A (zh) 2013-08-16
US20140348875A1 (en) 2014-11-27
US20170028057A1 (en) 2017-02-02
PL2797627T3 (pl) 2021-06-28
PH12014501388A1 (en) 2014-09-22
JP2016195593A (ja) 2016-11-24
RS61261B1 (sr) 2021-01-29
UA119786C2 (uk) 2019-08-12
UA114719C2 (uk) 2017-07-25
RU2014131474A (ru) 2016-02-20
JP2015503914A (ja) 2015-02-05
RU2662768C2 (ru) 2018-07-31
MD4481C1 (ro) 2017-12-31
IL232902A0 (en) 2014-07-31

Similar Documents

Publication Publication Date Title
US9931396B2 (en) Koi herpesvirus vaccine
CN107805631B (zh) 编码传染性喉气管炎病毒和新城疫病毒抗原的重组非致病性马立克氏病病毒构建体
EP2195021B1 (en) A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
CN105695423B (zh) 表达传染性法氏囊病毒vp2基因的重组鸡马立克氏病病毒疫苗株及其构建方法和应用
CN110628730B (zh) 表达猪繁殖与呼吸综合征病毒gp蛋白的重组猪伪狂犬病病毒及应用
JP7092663B2 (ja) 組換えオルフウイルスベクター
JP7387623B2 (ja) 標的タンパク質を安定して発現できる組換えウイルス
JP2017526737A (ja) 組み換え血清型９トリアデノウイルスベクター形式でのワクチン
CN102277368A (zh) 鸭病毒性肠炎病毒感染性重组克隆系统及构建方法和应用
EP2031065A1 (en) A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi
WO2025044922A2 (en) Vectored dev avian influenza h9 vaccines
CN105385666A (zh) 伪狂犬病病毒双荧光标记5基因缺失株的构建
KR20260066090A (ko) 신규한 dev 벡터
CN114807062B (zh) 非洲猪瘟病毒i73r基因条件性缺失毒株的构建及其作为疫苗的应用
Afshar et al. Comprehensive Review of Fowl and Duck Adenovirus Vaccines Development: Innovations, Challenges, and Future Directions.
CN113388641A (zh) 一种禽4型腺病毒载体、构建方法及其减毒活疫苗和应用
WO2025044920A2 (en) New dev vectors for avian vaccines
JP2004531254A (ja) Ｅｈｖ配列を含む人工染色体
CN118028252A (zh) 表达ciav vp1和vp2基因的重组鸡马立克病病毒疫苗株及其应用
CN118813706A (zh) 表达传染性法氏囊病病毒vp2基因的重组新城疫病毒疫苗株及其构建方法与应用
CN121931060A (zh) 用于预防或治疗由鳗鲡疱疹病毒1引起的疾病的重组鳗鲡疱疹病毒1

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150728

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160414

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160602

TRDD Decision of grant or rejection written
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20160701

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160701

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160729

R150 Certificate of patent or registration of utility model

Ref document number: 5982009

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250